ProQR Therapeutics N.V.(PRQR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PRQR ProQR Therapeutics N.V.

交易中 02-09 13:13:34 EST

1.46

-0.04

-2.67%

最高1.55	最低1.45	成交量13.40万
今开1.55	昨收1.50	日振幅6.67%
总市值1.54亿	流通市值9,859万	总股本1.05亿
成交额19.71万	换手率0.20%	流通股本6,753万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PRQR","market":"US","secType":"STK","nameCN":"ProQR Therapeutics N.V.","latestPrice":1.46,"timestamp":1770660803374,"preClose":1.5,"halted":0,"volume":134019,"delay":0,"changeRate":-0.02666666666666669,"floatShares":67530657,"shares":105345192,"eps":-0.482307,"marketStatus":"交易中","change":-0.04,"latestTime":"02-09 13:13:34 EST","open":1.55,"high":1.55,"low":1.45,"amount":197112.3576048,"amplitude":0.066667,"askPrice":1.47,"askSize":187,"bidPrice":1.46,"bidSize":2143,"shortable":3,"etf":0,"ttmEps":-0.482307,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770670800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1411012800000,"exchange":"NASDAQ","adjPreClose":1.5,"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"16:10 EST","volume":4,"amount":6,"timestamp":1770412204934,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.524975,"impliedVol":0.9981,"impliedVolPercentile":0.6534},"requestUrl":"/m/hq/s/PRQR","defaultTab":"news","newsList":[{"id":"1186686111","title":"ProQR Therapeutics NV：初步Ax-0810数据显示给药四周后无安全性信号，药代动力学与非临床数据一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1186686111","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186686111?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:04","pubTimestamp":1767877499,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV近日公布其候选药物Ax-0810的初期临床研究结果。数据显示，在为期四周的给药周期后，未观察到任何安全性警示信号。同时，该药物的药代动力学特征与此前的非临床研究数据高度吻合，进一步验证了其可控的代谢特性和潜在的治疗窗口。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"1174070940","title":"ProQR公布Ax-0810一期临床试验积极安全性及药代动力学数据，确定开发候选药物并展望2026年","url":"https://stock-news.laohu8.com/highlight/detail?id=1174070940","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174070940?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:02","pubTimestamp":1767877344,"startTime":"0","endTime":"0","summary":"生物技术公司ProQR Therapeutics NV（NASDAQ: PRQR）近日披露了其研发管线的重要进展。公司宣布，针对Ax-0810的一期临床试验获得了令人鼓舞的安全性和药代动力学（PK）数据，初步结果显示该药物在受试者中耐受性良好，药代动力学特征符合预期，为后续临床开发奠定了坚实基础。\n与此同时，ProQR已正式确定Ax-0810作为重点开发候选药物，将加快推进其后续临床研究计划。公司还同步更新了其研发战略与远期规划，明确了至2026年的发展目标与预期里程碑，展现出对创新疗法持续投入的决心与清晰路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"1150219346","title":"ProQR Therapeutics 第三季度每股收益为-0.1欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150219346","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150219346?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571455,"startTime":"0","endTime":"0","summary":"11月6日报道 - ProQR Therapeutics 第三季度营业收入为288.2万欧元，低于IBES预期的437万欧元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"1106429468","title":"ProQR获得Ax-0810的CTA授权，并宣布于2025年11月3日举行线上投资者与分析师活动","url":"https://stock-news.laohu8.com/highlight/detail?id=1106429468","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106429468?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:01","pubTimestamp":1760961707,"startTime":"0","endTime":"0","summary":"ProQR获得Ax-0810的CTA授权，并宣布于2025年11月3日举行线上投资者与分析师活动","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2518209244","title":"Proqr Therapeutics N.V.盘中异动 下午盘股价大跌5.24%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209244?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:37","pubTimestamp":1741631830,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时37分，Proqr Therapeutics N.V.股票出现波动，股价急速下跌5.24%。截至发稿，该股报1.81美元/股，成交量51.4288万股，换手率0.49%，振幅8.30%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.55%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023710abf36c6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023710abf36c6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2517607943","title":"Proqr Therapeutics N.V.盘中异动 急速上涨5.69%报2.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517607943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517607943?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:41","pubTimestamp":1741185695,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时41分，Proqr Therapeutics N.V.股票出现异动，股价急速上涨5.69%。截至发稿，该股报2.14美元/股，成交量1.2014万股，换手率0.01%，振幅5.94%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.69%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224135989d4830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224135989d4830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRQR","LENZ","BK4139"],"gpt_icon":0},{"id":"2517986724","title":"Proqr Therapeutics N.V.盘中异动 临近收盘大幅下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517986724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517986724?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:00","pubTimestamp":1741122024,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日05时00分，Proqr Therapeutics N.V.股票出现异动，股价快速跳水5.16%。截至发稿，该股报2.02美元/股，成交量48.0434万股，换手率0.45%，振幅5.16%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.31%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305050024989c05b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305050024989c05b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRQR"],"gpt_icon":0},{"id":"2514856100","title":"Proqr Therapeutics N.V.盘中异动 早盘急速上涨9.17%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856100?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:43","pubTimestamp":1740580999,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时43分，Proqr Therapeutics N.V.股票出现波动，股价快速拉升9.17%。截至发稿，该股报2.55美元/股，成交量466股，换手率0.00%，振幅0.85%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.48%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224319abddf00c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224319abddf00c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR","BK4139"],"gpt_icon":0},{"id":"2514129360","title":"Proqr Therapeutics N.V.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514129360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514129360?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:21","pubTimestamp":1740504081,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时21分，Proqr Therapeutics N.V.股票出现异动，股价快速跳水5.18%。截至发稿，该股报2.38美元/股，成交量11.2507万股，换手率0.11%，振幅4.78%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.27%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601212298926f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601212298926f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR","BK4139"],"gpt_icon":0},{"id":"2512216546","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512216546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512216546?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:42","pubTimestamp":1739889738,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时42分，Proqr Therapeutics N.V.股票出现波动，股价急速上涨5.17%。截至发稿，该股报2.55美元/股，成交量1.5655万股，换手率0.01%，振幅4.96%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.55%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224219962799bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224219962799bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRQR"],"gpt_icon":0},{"id":"2511861594","title":"Proqr Therapeutics N.V.盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511861594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511861594?lang=zh_cn&edition=full","pubTime":"2025-02-15 02:10","pubTimestamp":1739556617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日02时10分，Proqr Therapeutics N.V.股票出现异动，股价快速上涨5.29%。截至发稿，该股报2.39美元/股，成交量5.2392万股，换手率0.05%，振幅5.73%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.54%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215021017abcf34de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215021017abcf34de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2510380549","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大跌5.19%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380549?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:37","pubTimestamp":1739284623,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时37分，Proqr Therapeutics N.V.股票出现异动，股价急速下跌5.19%。截至发稿，该股报2.01美元/股，成交量3.8138万股，换手率0.04%，振幅4.75%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.91%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223703961f48b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223703961f48b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2510281861","title":"Proqr Therapeutics N.V.盘中异动 临近收盘股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510281861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510281861?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:49","pubTimestamp":1739220583,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时49分，Proqr Therapeutics N.V.股票出现异动，股价快速下挫5.33%。截至发稿，该股报2.13美元/股，成交量22.8712万股，换手率0.22%，振幅4.00%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.94%。Proqr Therapeutics N.V.公司简介：ProQR Therapeutics NV 是一家生物制药公司。该公司为囊性纤维化，Leber's congenital amaurosis type 10 和 dyastrophic epidermolysis bullosa 等严重遗传性罕见疾病患者发现和开发 RNA 治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211044943a240ef11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211044943a240ef11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR","BK4139"],"gpt_icon":0},{"id":"2509777810","title":"Proqr Therapeutics N.V.盘中异动 下午盘大幅跳水5.00%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509777810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509777810?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:49","pubTimestamp":1738954197,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时49分，Proqr Therapeutics N.V.股票出现异动，股价急速跳水5.00%。截至发稿，该股报2.28美元/股，成交量11.4699万股，换手率0.11%，振幅5.83%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为8089.15%、178.48%、127.70%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、56.40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208024957987dd914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208024957987dd914&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRQR"],"gpt_icon":0},{"id":"2509023509","title":"Proqr Therapeutics N.V.盘中异动 股价大涨5.35%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509023509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509023509?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:17","pubTimestamp":1738772226,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时17分，Proqr Therapeutics N.V.股票出现波动，股价快速上涨5.35%。截至发稿，该股报2.32美元/股，成交量4.1683万股，换手率0.04%，振幅6.46%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4257.31%、1759.35%、1305.21%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为99.51%、59.80%、54.05%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206001706987b8e65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206001706987b8e65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2508138122","title":"Proqr Therapeutics N.V.盘中异动 大幅拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508138122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508138122?lang=zh_cn&edition=full","pubTime":"2025-02-04 03:45","pubTimestamp":1738611908,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日03时45分，Proqr Therapeutics N.V.股票出现波动，股价快速上涨5.44%。截至发稿，该股报2.23美元/股，成交量18.3613万股，换手率0.17%，振幅8.04%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Invivyd, Inc.、Hcw Biologics Inc.、Gh Research Plc涨幅较大，Cyclerion Therapeutics, Inc.、Hcw Biologics Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为962.06%、733.20%、472.36%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、151.80%、63.94%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204034508a23847de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204034508a23847de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2507966303","title":"Proqr Therapeutics N.V.盘中异动 股价大跌6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507966303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507966303?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:30","pubTimestamp":1738333851,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时30分，Proqr Therapeutics N.V.股票出现波动，股价急速跳水6.05%。截至发稿，该股报2.02美元/股，成交量1146股，换手率0.00%，振幅0.00%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nls Pharmaceutics Ltd.、Nutriband Inc C/Wts 涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1048.01%、205.40%、52.98%，振幅较大的相关个股有Eyenovia, Inc.、Channel Therapeutics Corporation、Nls Pharmaceutics Ltd.，振幅分别为11.17%、4.92%、4.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312230519614ea86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312230519614ea86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2507620164","title":"Proqr Therapeutics N.V.盘中异动 早盘股价大涨5.03%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507620164?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:53","pubTimestamp":1738252412,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时53分，Proqr Therapeutics N.V.股票出现异动，股价大幅拉升5.03%。截至发稿，该股报2.09美元/股，成交量27.2128万股，换手率0.26%，振幅4.77%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1575.35%、203.63%、195.53%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为61.86%、61.86%、56.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235332961446fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235332961446fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRQR","LENZ"],"gpt_icon":0},{"id":"2505000208","title":"Proqr Therapeutics N.V.盘中异动 快速下跌5.06%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505000208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505000208?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:52","pubTimestamp":1737474739,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时52分，Proqr Therapeutics N.V.股票出现异动，股价大幅下跌5.06%。截至发稿，该股报2.25美元/股，成交量6.1524万股，换手率0.06%，振幅8.19%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为1.72%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为738.50%、439.80%、179.05%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121235219960bc935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121235219960bc935&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRQR","BK4139"],"gpt_icon":0},{"id":"2504162331","title":"Proqr Therapeutics N.V.盘中异动 急速上涨5.65%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504162331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504162331?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:50","pubTimestamp":1737125433,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时50分，Proqr Therapeutics N.V.股票出现异动，股价急速上涨5.65%。截至发稿，该股报2.43美元/股，成交量1.4277万股，换手率0.01%，振幅4.78%。Proqr Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Channel Therapeutics Corporation涨幅较大，Aditxt, Inc.、Aeon Biopharma, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为127.63%、18.15%、12.55%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为51.37%、47.91%、42.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117225033a225c02a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117225033a225c02a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRQR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.proqr.com","stockEarnings":[{"period":"1week","weight":-0.0741},{"period":"1month","weight":-0.3056},{"period":"3month","weight":-0.3243},{"period":"6month","weight":-0.3088},{"period":"1year","weight":-0.375},{"period":"ytd","weight":-0.2574}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProQR Therapeutics N.V.是一家于2012年2月21日在荷兰成立的有限责任公司。该公司是一家生物技术公司，致力于创造变革性的RNA疗法，以改善受高度未满足医疗需求的疾病影响的患者和家庭的生活。为实现这一目标，该公司正在推进专有的Axiomer RNA编辑平台技术。公司候选产品旨在利用腺苷脱氨酶作用于RNA（“ADAR”）进行靶向RNA编辑，公司认为这有潜力成为一类新型创新药物，适用于广泛的治疗领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.145657},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.090561},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.002169},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.01976},{"month":5,"riseRate":0.454545,"avgChangeRate":0.024621},{"month":6,"riseRate":0.545455,"avgChangeRate":0.033196},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.028536},{"month":8,"riseRate":0.818182,"avgChangeRate":0.084656},{"month":9,"riseRate":0.272727,"avgChangeRate":0.07181},{"month":10,"riseRate":0.333333,"avgChangeRate":0.038791},{"month":11,"riseRate":0.583333,"avgChangeRate":0.041178},{"month":12,"riseRate":0.583333,"avgChangeRate":0.201624}],"exchange":"NASDAQ","name":"ProQR Therapeutics N.V.","nameEN":"ProQR Therapeutics NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProQR Therapeutics N.V.(PRQR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProQR Therapeutics N.V.(PRQR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProQR Therapeutics N.V.,PRQR,ProQR Therapeutics N.V.股票,ProQR Therapeutics N.V.股票老虎,ProQR Therapeutics N.V.股票老虎国际,ProQR Therapeutics N.V.行情,ProQR Therapeutics N.V.股票行情,ProQR Therapeutics N.V.股价,ProQR Therapeutics N.V.股市,ProQR Therapeutics N.V.股票价格,ProQR Therapeutics N.V.股票交易,ProQR Therapeutics N.V.股票购买,ProQR Therapeutics N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProQR Therapeutics N.V.(PRQR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProQR Therapeutics N.V.(PRQR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}